Equity (Tables)

3 Months Ended

Dec. 31, 2022

Equity [Abstract]

Schedule of Stock-based Compensation Expense - By Award Type

The following table sets forth stock-based compensation expense by award type:

	Three Months Ended December 31,
(in thousands)	2022		2021
Employee stock options	$	—	$	—
RSUs and RSAs	915		554
PSUs and PRSAs	693		407
Outside director equity awards and fees in common stock	126		127
Total stock-based compensation expense	$	1,734	$	1,088

Schedule of Stock-based Compensation Expense - By Expense Type

The following table sets forth stock-based compensation expense by expense type:

	Three Months Ended December 31,
(in thousands)	2022		2021
Cost of revenue	$	387	$	151
Selling, general, and administrative	1,075		755
Research and development	272		182
Total stock-based compensation expense	$	1,734	$	1,088

Schedule of (Loss) Income Per Share

The following table sets forth the computation of basic and diluted net (loss) income per share:

	Three Months Ended December 31,
(in thousands, except per share data)	2022		2021
Numerator
Net (loss) income	$	(11,693)	$	2,414
Denominator
Weighted average number of shares outstanding - basic	37,557		36,950
Effect of dilutive securities
Stock options	—		7
PSUs, RSUs, and restricted stock	—		2,074
Weighted average number of shares outstanding - diluted	37,557		39,031
Earnings per share - basic	$	(0.31)	$	0.07
Earnings per share - diluted	$	(0.31)	$	0.06
Weighted average antidilutive options, unvested RSUs and RSAs, and unvested PSUs excluded from the computation	2,807		53

Schedule of Common Stock Reserved for Future Issuances

Common stock reserved for future issuances as of December 31, 2022 was as follows:

	Amount
Exercise of outstanding stock options	9,981
Unvested RSUs and RSAs	2,644,870
Unvested PSUs and PRSAs (at 200% maximum payout)	2,722,106
Issuance of stock-based awards under the Equity Plans	1,128,932
Purchases under the officer and director share purchase plan	88,741
Total reserved	6,594,630